Eli Lilly | LLY - Ebit





Ebit Veränderung Datum
AbbVie USD 6.72B 1.99B 2026-06
Abbott USD 1.36B 775M 2026-09
ALKERMES USD -65.93M 17.65M 2026-06
Amgen USD 4.61B 777M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
Baxter International USD 314M 38M 2026-09
Biogen USD 419.5M 663.3M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Coherus Biosciences USD -39.08M 3.65M 2025-12
Drreddys Laboratories INR 3.05B 13.32B 2026-03
Eli Lilly USD 13.09B 635M 2026-09
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
Glaxosmithkline GBP 2.31B 14.92M 2026-03
J&J USD 6.47B 1B 2026-09
Medtronic USD 1.84B 254M 2026-06
Merck USD 7.33B 6.49B 2026-09
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
Novartis USD 4.73B 549M 2026-06
Novartis USD 4.18B 118M 2026-03
Novo Nordisk DKK 33.76B 25.86B 2026-06
Perrigo USD 33.6M 50.8M 2026-03
Pfizer USD -180M 5.16B 2026-06
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 52.52M 22.97M 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 1.12B 811M 2026-06
Sanofi EUR 2.18B 1.56B 2026-03
United Therapeutics USD 375.6M 49.8M 2026-06
Zoetis USD 1.12B 279M 2026-06